QUIA.ST
QuiaPEG Pharmaceuticals Holding AB (publ) [QUIA.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
QUIA.ST Stock Summary
Top 10 Correlated ETFs
QUIA.ST
Top 10 Correlated Stocks
QUIA.ST
In the News
QUIA.ST Financial details
Company Rating
-
Market Cap
4.46M
Income
-15.69M
Revenue
3.08M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
30 Sep 2022
P/E
-0.03
Forward P/E
-
PEG
0.01
P/S
-
P/B
0.04
P/C
-
P/FCF
-0.54
Quick Ratio
0.81
Current Ratio
1.21
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.22
EPS next Y
-
EPS next Q
-
EPS this Y
-99.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-74.27%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-53%
ROE
-213%
ROC
-0.34%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0261-2.4
52W High
-
52W Low
-
RSI
52
Rel Volume
0.7
Avg Volume
1.87M
Volume
1.32M
Perf Week
-26.32%
Perf Month
117.78%
Perf Quarter
-66.78%
Perf Half Y
-72%
-
-
-
-
Beta
0.921
-
-
Volatility
0%, 0%
Prev Close
3.16%
Price
0.0098
Change
1.03%
Company Profile
- Volume Average 1.87M
- Market Capitalization 4.46M
- Employee 4
- CEO Mr. Marcus Bosson
- Headquarters Solna,SE
- IPO Date 2005-06-21
-
Website
https://www.quiapeg.com 
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.
